Tumor Immunotherapy
Cancer Vaccines
Targeted Cancer Therapies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 15, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Serena Zanotta1, Domenico Galati1
1Hematology-Oncology and Stem Cell Transplantation Unit, Department of Hematology and Innovative Diagnostic, Istituto Nazionale Tumori-IRCCS-Fondazione "G. Pascale", 80131 Napoli, Italy.
This study found n/a. Further research is needed to understand the implications of these findings.
Area of Science:
Background: